NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Voltar para busca
Dado oficial do USPTO
ENVISIONONE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
12/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
30/03/2024
Data de registro
11/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/11/2025
Última transação
12/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2024-09-00
Primeiro uso no comércio
2024-09-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Fairfield, CT
Examinador
GREEN,ASHLEY ELIZABETH
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Envision Pharma Inc.
Representantes
Zachary A. Aria Blank Rome LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Web site hosting services for the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Software as a service (SAAS) serviceshosting software for use by others for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Designdevelopment and implementation of software and software platforms for the life sciencepharmaceutical and bio-pharmaceutical industries and academic research organisations; Software development for others in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations in the field of software configuration management; Providing a web hosting platform for the life sciencepharmaceutical and biopharmaceutical industries and academic research organisations; Installationmaintenancerepair and updating of computer software and computer software platforms for the life sciencepharmaceutical and bio-pharmaceutical industries and academic research organisations; Designdevelopment and implementation of software for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software as a service (SAAS) serviceshosting software for global use by others for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software development for others in the field of software configuration management for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Designdevelopment and implementation of software platforms that incorporate integrated and configurable software modules for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Platform as a service (PAAS) featuring computer software platforms incorporating integrated and configurable software modules for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software development for others in the field of software platform configuration management for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Technical support servicestechnical advice related to the repair of computer software; Technical support servicestechnical advice related to the maintenance of computer software; Consultancy services relating to software as a service (SAAS) services and the selection of software applications; Advisoryconsultancy and information services relating to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22/10/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22/10/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/09/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/09/2025
IUAF
USE AMENDMENT FILED
28/04/2025
EISU
TEAS STATEMENT OF USE RECEIVED
28/04/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2025
PUBO
PUBLISHED FOR OPPOSITION
14/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/11/2024
GNRT
NON-FINAL ACTION E-MAILED
20/11/2024
CNRT
NON-FINAL ACTION WRITTEN
20/11/2024
DOCK
ASSIGNED TO EXAMINER
10/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/09/2024
NWAP
NEW APPLICATION ENTERED
30/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENVISIONONE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.